← All companies
Axsome Therapeutics, Inc.
AXSM - Company ID 0001579428
Market cap$6.96 B
Rank#1144
Filings634
The table below shows Axsome Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $313.86M | $319.85M | $305.11M | $325.27M | $303.02M | $300.91M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $343.11M | $277.46M | $251.06M | $196.51M | $198.82M | $161.40M |
| Inventory | $42.58M | $37.88M | $31.52M | $23.77M | $18.44M | $16.32M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.